The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

Transforming the landscape of drug discovery with next-gen capabilities in obesity research, small molecule and antibody design, antibody-drug conjugate development, and interactive AI AlpaMeld Logo ...

GUILFORD, Conn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- InveniAI LLC, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power ...

In 2019, Evotec acquired Just Biotherapeutics, an AI/ML antibody discovery ... AI-small molecule discovery spaces Compared to the small molecule AI drug discovery ecosystem, this space is evolving ...

Absci's advanced de novo antibody design models will benefit from AMD's optimized AI solutions, potentially leading to reduced infrastructure costs and faster innovation cycles in drug discovery.

Bio-IT World Conference & Expo, the premier annual gathering of 3,000 innovators at the intersection of IT and life sciences, ...

Absci Corporation and Owkin have announced a partnership to combine their advanced AI platforms for the rapid discovery ... AI Drug Creation platform, including its de novo antibody design models ...

including in the company’s de novo antibody design models – or models that create new antibodies. AI has acquired a vital role in the drug discovery process, transforming the pharmaceutical ...

Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...

Bispecific antibodies (bispecifics) can simultaneously target two distinct antigens or epitopes, offering novel therapeutic strategies such as enhancing immune cell targeting of cancer cells or ...